![Improved cancer immunotherapy by a CD25-mimobody conferring selectivity to human interleukin-2]()
Improved cancer immunotherapy by a CD25-mimobody conferring selectivity to human interleukin-2Arenas-Ramirez, N.; Zou, C.; Popp, S.; Zingg, D.; Brannetti, B.; Wirth, E.; Calzascia, T.; Kovarik, J.; Sommer, L.; Zenke, G.; Woytschak, J.; Regnier, C. H.; Katopodis, A.; Boyman, O. · Science Translational Medicine · 2016